메뉴 건너뛰기




Volumn 65, Issue 3, 2013, Pages 329-339

Choosing wisely: The American College of Rheumatology's top 5 list of things physicians and patients should question

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY;

EID: 84874488697     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21930     Document Type: Article
Times cited : (82)

References (57)
  • 1
    • 75449099731 scopus 로고    scopus 로고
    • Medicine's ethical responsibility for health care reform: The Top Five list
    • Brody H,. Medicine's ethical responsibility for health care reform: the Top Five list. N Engl J Med 2010; 362: 283-5.
    • (2010) N Engl J Med , vol.362 , pp. 283-285
    • Brody, H.1
  • 2
    • 84860485822 scopus 로고    scopus 로고
    • Choosing wisely: Helping physicians and patients make smart decisions about their care
    • Cassel CK, Guest JA,. Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA 2012; 307: 1801-2.
    • (2012) JAMA , vol.307 , pp. 1801-1802
    • Cassel, C.K.1    Guest, J.A.2
  • 3
    • 0037022219 scopus 로고    scopus 로고
    • Medical professionalism in the new millennium: A physician charter
    • ABIM Foundation, American Board of Internal Medicine, ACP-ASIM Foundation, American College of Physicians-American Society of Internal Medicine, European Federation of Internal Medicine
    • ABIM Foundation, American Board of Internal Medicine, ACP-ASIM Foundation, American College of Physicians-American Society of Internal Medicine, European Federation of Internal Medicine. Medical professionalism in the new millennium: a physician charter. Ann Intern Med 2002; 136: 243-6.
    • (2002) Ann Intern Med , vol.136 , pp. 243-246
  • 6
    • 33144490691 scopus 로고    scopus 로고
    • Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians task force
    • DOI 10.1378/chest.129.1.174
    • Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest 2006; 129: 174-81. (Pubitemid 43265259)
    • (2006) Chest , vol.129 , Issue.1 , pp. 174-181
    • Guyatt, G.1    Gutterman, D.2    Baumann, M.H.3    Addrizzo-Harris, D.4    Hylek, E.M.5    Phillips, B.6    Raskob, G.7    Lewis, S.Z.8    Schunemann, H.9
  • 7
    • 67651229051 scopus 로고    scopus 로고
    • 'Marginal medicine': Targeting comparative effectiveness research to reduce waste
    • Hoffman A, Pearson SD,. 'Marginal medicine': targeting comparative effectiveness research to reduce waste. Health Aff (Millwood) 2009; 28: w710-8.
    • (2009) Health Aff (Millwood) , vol.28
    • Hoffman, A.1    Pearson, S.D.2
  • 8
    • 0033979858 scopus 로고    scopus 로고
    • Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens
    • Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA, and the American College of Pathologists. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med 2000; 124: 71-81. (Pubitemid 30053777)
    • (2000) Archives of Pathology and Laboratory Medicine , vol.124 , Issue.1 , pp. 71-81
    • Kavanaugh, A.1    Tomar, R.2    Reveille, J.3    Solomon, D.H.4    Homburger, H.A.5
  • 11
    • 84855822380 scopus 로고    scopus 로고
    • Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care
    • et al.
    • Qaseem A, Alguire P, Dallas P, Feinberg LE, Fitzgerald FT, Horwitch C, et al. Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care. Ann Intern Med 2012; 156: 147-9.
    • (2012) Ann Intern Med , vol.156 , pp. 147-149
    • Qaseem, A.1    Alguire, P.2    Dallas, P.3    Feinberg, L.E.4    Fitzgerald, F.T.5    Horwitch, C.6
  • 12
    • 0035015310 scopus 로고    scopus 로고
    • Is it useful to test for antibodies to extractable nuclear antigens in the presence of a negative antinuclear antibody on Hep-2 cells? [4]
    • DOI 10.1136/jcp.54.5.413
    • Thomson KF, Murphy A, Goodfield MJ, Misbah SA,. Is it useful to test for antibodies to extractable nuclear antigens in the presence of a negative antinuclear antibody on Hep-2 cells? [letter]. J Clin Pathol 2001; 54: 413. (Pubitemid 32458148)
    • (2001) Journal of Clinical Pathology , vol.54 , Issue.5 , pp. 413
    • Thomson, K.F.1    Murphy, A.2    Goodfield, M.J.D.3    Misbah, S.A.4
  • 14
    • 0029949454 scopus 로고    scopus 로고
    • Antinuclear antibody testing: A study of clinical utility
    • DOI 10.1001/archinte.156.13.1421
    • Slater CA, Davis RB, Shmerling RH,. Antinuclear antibody testing: a study of clinical utility. Arch Intern Med 1996; 156: 1421-5. (Pubitemid 26226936)
    • (1996) Archives of Internal Medicine , vol.156 , Issue.13 , pp. 1421-1425
    • Slater, C.A.1    Davis, R.B.2    Shmerling, R.H.3
  • 15
    • 0022073529 scopus 로고
    • A negative fluorescent antinuclear antibody test in a patient with Jo-1 antibody
    • Bahrt KM, McCarty GA,. A negative fluorescent antinuclear antibody test in a patient with Jo-1 antibody. J Rheumatol 1985; 12: 624-5.
    • (1985) J Rheumatol , vol.12 , pp. 624-625
    • Bahrt, K.M.1    McCarty, G.A.2
  • 16
    • 0036892180 scopus 로고    scopus 로고
    • Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests
    • Hoffman IE, Peene I, Veys EM, De Keyser F,. Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests. Clin Chem 2002; 48: 2171-6. (Pubitemid 35397559)
    • (2002) Clinical Chemistry , vol.48 , Issue.12 , pp. 2171-2176
    • Hoffman, I.E.A.1    Peene, I.2    Veys, E.M.3    De Keyser, F.4
  • 17
    • 1642399760 scopus 로고    scopus 로고
    • Methods of choice for diagnostic antinuclear antibody (ANA) screening: Benefit of adding antigen-specific assays to immunofluorescence microscopy
    • DOI 10.1016/j.jaut.2003.12.004, PII S089684110300194X
    • Dahle C, Skogh T, Aberg AK, Jalal A, Olcen P,. Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy. J Autoimmun 2004; 22: 241-8. (Pubitemid 38369185)
    • (2004) Journal of Autoimmunity , vol.22 , Issue.3 , pp. 241-248
    • Dahle, C.1    Skogh, T.2    Aberg, A.K.3    Jalal, A.4    Olcen, P.5
  • 18
    • 28044462897 scopus 로고    scopus 로고
    • Antibodies to extractable nuclear antigens in antinuclear antibody-negative samples [6]
    • DOI 10.1373/clinchem.2005.058552
    • Bossuyt X, Luyckx A,. Antibodies to extractable nuclear antigens in antinuclear antibody-negative samples [letter]. Clin Chem 2005; 51: 2426-7. (Pubitemid 41692609)
    • (2005) Clinical Chemistry , vol.51 , Issue.12 , pp. 2426-2427
    • Bossuyt, X.1    Luyckx, A.2
  • 20
    • 84874505606 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention
    • Centers for Disease Control and Prevention. Lyme disease diagnosis and treatment. 2011. URL: www.cdc.gov/lyme/diagnosistreatment/index.html.
    • (2011) Lyme Disease Diagnosis and Treatment
  • 21
    • 0031439003 scopus 로고    scopus 로고
    • Guidelines for laboratory evaluation in the diagnosis of Lyme disease
    • American College of Physicians
    • American College of Physicians. Guidelines for laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 1997; 127: 1106-8.
    • (1997) Ann Intern Med , vol.127 , pp. 1106-1108
  • 22
    • 84864812174 scopus 로고    scopus 로고
    • Lyme disease
    • Hu LT,. Lyme disease. Ann Intern Med 2012; 157: ITC2-1.
    • (2012) Ann Intern Med , vol.157
    • Hu, L.T.1
  • 24
    • 0032554140 scopus 로고    scopus 로고
    • Tick bites and lyme disease in an endemic: Setting problematic use of serologic testing and prophylactic antibiotic therapy
    • DOI 10.1001/jama.279.3.206
    • Fix AD, Strickland GT, Grant J,. Tick bites and Lyme disease in an endemic setting: problematic use of serologic testing and prophylactic antibiotic therapy. JAMA 1998; 279: 206-10. (Pubitemid 28133782)
    • (1998) Journal of the American Medical Association , vol.279 , Issue.3 , pp. 206-210
    • Fix, A.D.1    Strickland, G.T.2    Grant, J.3
  • 28
    • 0028009435 scopus 로고
    • The use of serologic tests for Lyme disease in a prepaid health plan in California
    • DOI 10.1001/jama.271.6.460
    • Ley C, Le C, Olshen EM, Reingold AL,. The use of serologic tests for Lyme disease in a prepaid health plan in California. JAMA 1994; 271: 460-3. (Pubitemid 24043877)
    • (1994) Journal of the American Medical Association , vol.271 , Issue.6 , pp. 460-463
    • Ley, C.1    Le, C.2    Olshen, E.M.3    Reingold, A.L.4
  • 29
    • 0032030801 scopus 로고    scopus 로고
    • The consequences of overdiagnosis and overtreatment of Lyme disease: An observational study
    • Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI,. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med 1998; 128: 354-62. (Pubitemid 28103103)
    • (1998) Annals of Internal Medicine , vol.128 , Issue.5 , pp. 354-362
    • Reid, M.C.1    Schoen, R.T.2    Evans, J.3    Rosenberg, J.C.4    Horwitz, R.I.5
  • 30
    • 0031027867 scopus 로고    scopus 로고
    • Diagnosis and treatment of lyme arthritis
    • DOI 10.1016/S0025-7125(05)70510-1
    • Steere AC,. Diagnosis and treatment of Lyme arthritis. Med Clin North Am 1997; 81: 179-94. (Pubitemid 27043800)
    • (1997) Medical Clinics of North America , vol.81 , Issue.1 , pp. 179-194
    • Steere, A.C.1
  • 31
    • 84859832981 scopus 로고    scopus 로고
    • 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
    • et al.
    • Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012; 64: 625-39.
    • (2012) Arthritis Care Res (Hoboken) , vol.64 , pp. 625-639
    • Singh, J.A.1    Furst, D.E.2    Bharat, A.3    Curtis, J.R.4    Kavanaugh, A.F.5    Kremer, J.M.6
  • 33
    • 33646434237 scopus 로고    scopus 로고
    • Extremity magnetic resonance imaging in rheumatoid arthritis: Report of the American College of Rheumatology Extremity Magnetic Resonance Imaging Task Force
    • American College of Rheumatology Extremity Magnetic Resonance Imaging Task Force
    • American College of Rheumatology Extremity Magnetic Resonance Imaging Task Force. Extremity magnetic resonance imaging in rheumatoid arthritis: report of the American College of Rheumatology Extremity Magnetic Resonance Imaging Task Force. Arthritis Rheum 2006; 54: 1034-47.
    • (2006) Arthritis Rheum , vol.54 , pp. 1034-1047
  • 34
    • 79952379852 scopus 로고    scopus 로고
    • The value of magnetic resonance imaging and ultrasound in undifferentiated arthritis: A systematic review
    • Machado PM, Koevoets R, Bombardier C, van der Heijde DM,. The value of magnetic resonance imaging and ultrasound in undifferentiated arthritis: a systematic review. J Rheumatol Suppl 2011; 87: 31-7.
    • (2011) J Rheumatol , vol.87 , Issue.SUPPL. , pp. 31-37
    • MacHado, P.M.1    Koevoets, R.2    Bombardier, C.3    Van Der Heijde, D.M.4
  • 35
    • 84856548590 scopus 로고    scopus 로고
    • Magnetic resonance imaging in psoriatic arthritis: Update on current status and future perspectives: A report from the GRAPPA 2010 annual meeting
    • Ostergaard M, Poggenborg RP,. Magnetic resonance imaging in psoriatic arthritis: update on current status and future perspectives: a report from the GRAPPA 2010 annual meeting. J Rheumatol 2012; 39: 408-12.
    • (2012) J Rheumatol , vol.39 , pp. 408-412
    • Ostergaard, M.1    Poggenborg, R.P.2
  • 37
    • 79958785924 scopus 로고    scopus 로고
    • Role of magnetic resonance imaging in the diagnosis and prognosis of rheumatoid arthritis
    • Suter LG, Fraenkel L, Braithwaite RS,. Role of magnetic resonance imaging in the diagnosis and prognosis of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2011; 63: 675-88.
    • (2011) Arthritis Care Res (Hoboken) , vol.63 , pp. 675-688
    • Suter, L.G.1    Fraenkel, L.2    Braithwaite, R.S.3
  • 38
    • 79955069103 scopus 로고    scopus 로고
    • Cost-effectiveness of adding magnetic resonance imaging to rheumatoid arthritis management
    • Suter LG, Fraenkel L, Braithwaite RS,. Cost-effectiveness of adding magnetic resonance imaging to rheumatoid arthritis management. Arch Intern Med 2011; 171: 657-67.
    • (2011) Arch Intern Med , vol.171 , pp. 657-667
    • Suter, L.G.1    Fraenkel, L.2    Braithwaite, R.S.3
  • 39
    • 77953696525 scopus 로고    scopus 로고
    • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
    • et al.
    • Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010; 69: 964-75.
    • (2010) Ann Rheum Dis , vol.69 , pp. 964-975
    • Smolen, J.S.1    Landewe, R.2    Breedveld, F.C.3    Dougados, M.4    Emery, P.5    Gaujoux-Viala, C.6
  • 40
    • 79953041295 scopus 로고    scopus 로고
    • Treatment of early rheumatoid arthritis: Concepts in management
    • Haraoui B, Pope J,. Treatment of early rheumatoid arthritis: concepts in management. Semin Arthritis Rheum 2011; 40: 371-88.
    • (2011) Semin Arthritis Rheum , vol.40 , pp. 371-388
    • Haraoui, B.1    Pope, J.2
  • 41
    • 79952219360 scopus 로고    scopus 로고
    • Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: A systematic review
    • et al. [review]
    • Van der Velde G, Pham B, Machado M, Ieraci L, Witteman W, Bombardier C, et al. Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: a systematic review [review]. Arthritis Care Res (Hoboken) 2011; 63: 65-78.
    • (2011) Arthritis Care Res (Hoboken) , vol.63 , pp. 65-78
    • Van Der Velde, G.1    Pham, B.2    MacHado, M.3    Ieraci, L.4    Witteman, W.5    Bombardier, C.6
  • 42
    • 77950357873 scopus 로고    scopus 로고
    • Cost-effectiveness of biologics in early rheumatoid arthritis
    • [letter]
    • Finckh A, Bansback N, Liang MH,. Cost-effectiveness of biologics in early rheumatoid arthritis [letter]. Ann Intern Med 2010; 152: 333-4.
    • (2010) Ann Intern Med , vol.152 , pp. 333-334
    • Finckh, A.1    Bansback, N.2    Liang, M.H.3
  • 43
    • 79951581065 scopus 로고    scopus 로고
    • American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
    • et al.
    • Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 2010; 62: 1515-26.
    • (2010) Arthritis Care Res (Hoboken) , vol.62 , pp. 1515-1526
    • Grossman, J.M.1    Gordon, R.2    Ranganath, V.K.3    Deal, C.4    Caplan, L.5    Chen, W.6
  • 44
    • 77954254610 scopus 로고    scopus 로고
    • National Osteoporosis Foundation. Washington, DC: National Osteoporosis Foundation
    • National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010. p. 1-36.
    • (2010) Clinician's Guide to Prevention and Treatment of Osteoporosis , pp. 1-36
  • 45
    • 79952230364 scopus 로고    scopus 로고
    • Screening for osteoporosis: US Preventive Services Task Force recommendation statement
    • US Preventive Services Task Force
    • US Preventive Services Task Force. Screening for osteoporosis: US Preventive Services Task Force recommendation statement. Ann Intern Med 2011; 154: 356-64.
    • (2011) Ann Intern Med , vol.154 , pp. 356-364
  • 47
    • 84855666535 scopus 로고    scopus 로고
    • Medicare payment cuts for osteoporosis testing reduced use despite tests' benefit in reducing fractures
    • King AB, Fiorentino DM,. Medicare payment cuts for osteoporosis testing reduced use despite tests' benefit in reducing fractures. Health Aff (Millwood) 2011; 30: 2362-70.
    • (2011) Health Aff (Millwood) , vol.30 , pp. 2362-2370
    • King, A.B.1    Fiorentino, D.M.2
  • 48
    • 77954288455 scopus 로고    scopus 로고
    • Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: Application of the systemic lupus erythematosus quality indicators
    • Schmajuk G, Yelin E, Chakravarty E, Nelson LM, Panopolis P, Yazdany J,. Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators. Arthritis Care Res (Hoboken) 2010; 62: 993-1001.
    • (2010) Arthritis Care Res (Hoboken) , vol.62 , pp. 993-1001
    • Schmajuk, G.1    Yelin, E.2    Chakravarty, E.3    Nelson, L.M.4    Panopolis, P.5    Yazdany, J.6
  • 49
    • 0034092979 scopus 로고    scopus 로고
    • Prediction of fracture from low bone mineral density measurements overestimates risk
    • DOI 10.1016/S8756-3282(00)00238-6, PII S8756328200002386
    • Kanis JA, Johnell O, Oden A, Jonsson B, De Laet C, Dawson A,. Prediction of fracture from low bone mineral density measurements overestimates risk. Bone 2000; 26: 387-91. (Pubitemid 30136130)
    • (2000) Bone , vol.26 , Issue.4 , pp. 387-391
    • Kanis, J.A.1    Johnell, O.2    Oden, A.3    Jonsson, B.4    De Laet, C.5    Dawson, A.6
  • 51
    • 84863347003 scopus 로고    scopus 로고
    • Central DXA utilization shifts from office-based to hospital-based settings among Medicare beneficiaries in the wake of reimbursement changes
    • et al.
    • Zhang J, Delzell E, Zhao H, Laster AJ, Saag KG, Kilgore ML, et al. Central DXA utilization shifts from office-based to hospital-based settings among Medicare beneficiaries in the wake of reimbursement changes. J Bone Miner Res 2012; 27: 858-64.
    • (2012) J Bone Miner Res , vol.27 , pp. 858-864
    • Zhang, J.1    Delzell, E.2    Zhao, H.3    Laster, A.J.4    Saag, K.G.5    Kilgore, M.L.6
  • 52
    • 84862908900 scopus 로고    scopus 로고
    • Bone-density testing interval and transition to osteoporosis in older women
    • et al.
    • Gourlay ML, Fine JP, Preisser JS, May RC, Li C, Lui LY, et al. Bone-density testing interval and transition to osteoporosis in older women. N Engl J Med 2012; 366: 225-33.
    • (2012) N Engl J Med , vol.366 , pp. 225-233
    • Gourlay, M.L.1    Fine, J.P.2    Preisser, J.S.3    May, R.C.4    Li, C.5    Lui, L.Y.6
  • 53
    • 28144450564 scopus 로고    scopus 로고
    • Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: Reduction in risk of nonvertebral fracture is not related to change in BMD
    • DOI 10.1359/JBMR.050814
    • Watts NB, Geusens P, Barton IP, Felsenberg D,. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD. J Bone Miner Res 2005; 20: 2097-104. (Pubitemid 41698773)
    • (2005) Journal of Bone and Mineral Research , vol.20 , Issue.12 , pp. 2097-2104
    • Watts, N.B.1    Geusens, P.2    Barton, I.P.3    Felsenberg, D.4
  • 54
    • 0037125875 scopus 로고    scopus 로고
    • Screening for postmenopausal osteoporosis: A review of the evidence for the U.S. Preventive Services Task Force
    • Nelson HD, Helfand M, Woolf SH, Allan JD,. Screening for postmenopausal osteoporosis: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002; 137: 529-41. (Pubitemid 35024625)
    • (2002) Annals of Internal Medicine , vol.137 , Issue.6 , pp. 529-541
    • Nelson, H.D.1    Helfand, M.2    Woolf, S.H.3    Allan, J.D.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.